# Antidepressants During Pregnancy Not Linked to Autism, ADHD
A new study reassures pregnant women taking antidepressants. Researchers found no connection between prenatal antidepressant use and autism or ADHD in children.
The findings matter because many women stop or avoid antidepressants during pregnancy due to safety concerns. This leaves them vulnerable to untreated depression, which carries its own risks for both mother and baby.
The research examined data from thousands of pregnancies where mothers used selective serotonin reuptake inhibitors (SSRIs) and other common antidepressants. Children born to these mothers showed no increased rates of autism spectrum disorder or attention-deficit/hyperactivity disorder compared to unexposed children.
Untreated maternal depression during pregnancy poses real dangers. It links to premature birth, lower birth weight, and developmental delays. Depression also increases the risk of postpartum depression, which affects bonding and infant care.
Dr. [researcher name, if available] emphasized that mothers should not abruptly stop antidepressants without consulting their doctor. Suddenly stopping these medications can trigger withdrawal symptoms and a return of depression, both hazardous during pregnancy.
The American College of Obstetricians and Gynecologists recommends that pregnant women with depression continue antidepressant treatment in most cases. The benefits of managing maternal mental health typically outweigh potential risks.
Pregnant women currently taking SSRIs like sertraline (Zoloft), paroxetine (Paxil), or fluoxetine (Prozac) should discuss their specific situation with their OB-GYN or psychiatrist. Some adjustments might be necessary, but abrupt discontinuation rarely makes sense.
This study adds to growing evidence that depression treatment during pregnancy protects both mother and